Choose Medical News By Speciality
Some feed pages can be slow to load
Some feed pages can be slow to load
Two studies show higher anti-S titers in those with previous infection and very strong T-cell responses
Improved outcomes, including more organ support-free days, reduced mortality, seen with tocilizumab, sarilumab
The schedule includes several new vaccines and some important clarifications.
In a retrospective observational study, measurement of HLA-DR on immunologically activated T cells distinguished recent from remote tuberculosis infection.
Airborne SARS-CoV-2 was more common in the household setting than the inpatient setting.
In Austria, infection during the first COVID-19 wave conferred 91% protection from reinfection during the second wave.
Nosocomial infections, common in critically ill patients with COVID-19, prolong ICU stay and raise risk for death.
Single Use Tubing Sets Brochure